Contribution of Involved-field Radiotherapy to Survival in Patients With Relapsed or Refractory Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation

Eroglu, CELALETTİN; KAYNAR, LEYLAGÜL; ORHAN, OKAN; Keklik, MUZAFFER; Sahin, Cem; YILDIZ, Orhan; Mentes, Selahattin; Kurnaz, Fatih; ASLAN, DİCLE; Sivgin, Serdar; Soyuer, Serdar; Eser, BÜLENT; Cetin, MUSTAFA; Unal, ALİ

doi:10.1097/coc.0b013e3182880b9f

Contribution of Involved-field Radiotherapy to Survival in Patients With Relapsed or Refractory Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation

Atıf İçin Kopyala

Eroglu C., KAYNAR L., ORHAN O., Keklik M., Sahin C., YILDIZ O., ...Daha Fazla

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.38, sa.1, ss.68-73, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 38 Sayı: 1
Basım Tarihi: 2015
Doi Numarası: 10.1097/coc.0b013e3182880b9f
Dergi Adı: AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.68-73
Anahtar Kelimeler: Hodgkin lymphoma, chemoradiotherapy, autologous stem cell transplantation, HIGH-DOSE CHEMOTHERAPY, BONE-MARROW-TRANSPLANTATION, RADIATION-THERAPY, EUROPEAN GROUP, WORKING PARTY, DISEASE, BLOOD, CHEMORADIOTHERAPY, PATTERNS, FAILURE
Erciyes Üniversitesi Adresli: Evet

Özet

Objectives: To assess the outcomes of overall survival and posttransplantation survival in patients with Hodgkin lymphoma (HL) undergoing autologous stem cell transplantation (ASCT) because of the development of relapse or resistance after chemotherapy (CT) or CT plus radiotherapy (combined modality treatment, CMT).